Systemic and local interleukin-17 and linked cytokines associated with Sjögren's syndrome immunopathogenesis.
Recently recognized as a distinct CD4(+) T helper (Th) lineage, Th17 cells have been implicated in host responses to infections and in pathogenesis associated with autoimmune diseases. This cytokine is implicated in primary Sjögren's syndrome (pSS) immunopathology because of the increased levels of circulating interleukin (IL)-17 in pSS. Plasma and minor salivary glands (MSGs) from patients with pSS were therefore evaluated for CD4(+) T cells, T regulatory cells, IL-17, and supporting cytokines by immunohistochemistry, RT-PCR, and microbead assays. MSGs from pSS patients contain IL-17-expressing cells as a dominant population within inflammatory lesions. IL-17 protein expression progressively increased with higher biopsy focus scores (P < 0.0001), in parallel with detection by RT-PCR. Transforming growth factor-beta, IL-6 and IL-23, which are requisite promoters of Th17 differentiation, were found in abundance compared with the amounts in control tissues. Although transforming growth factor-beta is also a pivotal differentiation factor for immunosuppressive Foxp3(+) T regulatory cells (Tregs), an increase in Foxp3(+) Tregs was evident in biopsy specimens with mild and moderate inflammation but this increase was disproportionate to escalating pro-inflammatory Th17 populations in advanced disease. Furthermore, the Th17-centric cytokines IL-17, IL-6, IL-23, and IL-12 were significantly elevated in pSS plasma. These data identify a profusion of IL-17-generating cells and supporting cytokines within diseased pSS MSGs without a compensatory increase in immunomodulatory Tregs; this imbalance seems to foster a pathogenic milieu that may be causative and predictive of infiltrative injury and amenable to therapeutic intervention.
Katsifis
Gikas E
GE
Oral Infection and Immunity Branch and Sjögren's Syndrome Clinic, National Institute of Dental and Craniofacial Research/NIH, 30 Convent Drive, Bethesda, MD 20892, USA.
Rekka
Sofia
S
Moutsopoulos
Niki M
NM
Pillemer
Stanley
S
Wahl
Sharon M
SM
D000328:Adult; D000368:Aged; D001706:Biopsy; D005260:Female; D051858:Forkhead Transcription Factors / Q000276:immunology; D006801:Humans; D007150:Immunohistochemistry; D018664:Interleukin-12 / Q000378:metabolism; D020381:Interleukin-17 / Q000378:metabolism*; D053759:Interleukin-23 / Q000378:metabolism; D015850:Interleukin-6 / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010865:Pilot Projects; D012469:Salivary Glands / Q000378:metabolism / Q000473:pathology; D012859:Sjogren's Syndrome / Q000209:etiology / Q000276:immunology / Q000378:metabolism*; D050378:T-Lymphocytes, Regulatory / Q000276:immunology; D016212:Transforming Growth Factor beta / Q000378:metabolism
C418974:FOXP3 protein, human; D051858:Forkhead Transcription Factors; D020381:Interleukin-17; D053759:Interleukin-23; D015850:Interleukin-6; D016212:Transforming Growth Factor beta; D018664:Interleukin-12
J Immunol. 2008 Dec 15;181(12):8391-401
19050256
Arthritis Rheum. 1997 May;40(5):987-90
9153568
J Immunol. 1994 Jun 1;152(11):5532-9
8189070
Nature. 2008 Jul 17;454(7202):350-2
18469800
Arthritis Rheum. 2007 Dec;56(12):3995-4004
18050196
Arthritis Rheum. 2006 Sep;54(9):2817-29
16947782
J Immunol. 2008 Aug 15;181(4):2898-906
18684981
Cell. 2006 Sep 22;126(6):1121-33
16990136
Clin Rev Allergy Immunol. 2007 Jun;32(3):252-64
17992592
N Engl J Med. 2007 Feb 8;356(6):580-92
17287478
Nature. 2006 May 11;441(7090):235-8
16648838
Immunity. 2006 Feb;24(2):179-89
16473830
Ann Rheum Dis. 2008 Oct;67(10):1437-43
18198195
Scand J Immunol. 2008 Dec;68(6):554-64
19000095
Immunity. 2009 Jan 16;30(1):92-107
19119024
Arthritis Rheum. 2008 Mar;58(3):734-43
18311793
Science. 2003 Feb 14;299(5609):1033-6
12532024
Am J Pathol. 2008 Nov;173(5):1389-96
18818377
J Autoimmun. 2005 May;24(3):235-42
15848046
Immunology. 2006 Mar;117(3):289-300
16476048
Nat Immunol. 2007 Dec;8(12):1390-7
17994024
Cytokine Growth Factor Rev. 2003 Apr;14(2):155-74
12651226
Nat Immunol. 2008 Jun;9(6):650-7
18454150
Oral Surg Oral Med Oral Pathol. 1974 Jan;37(1):64-74
4586901
J Exp Med. 2007 Aug 6;204(8):1849-61
17635957
Curr Opin Immunol. 2007 Feb;19(1):55-62
17137775
Nat Immunol. 2008 Jun;9(6):641-9
18454151
Clin Exp Immunol. 2002 Jun;128(3):562-8
12067313
Clin Exp Immunol. 2007 Mar;147(3):497-503
17302899
Immunity. 2008 Jan;28(1):29-39
18164222
Nature. 2006 May 11;441(7090):231-4
16648837
Immunity. 2004 Oct;21(4):467-76
15485625
Lancet. 2005 Jul 23-29;366(9482):321-31
16039337
J Immunol. 2004 Dec 15;173(12):7249-58
15585847
Arthritis Rheum. 1999 Aug;42(8):1765-72
10446879
Arthritis Rheum. 1996 Aug;39(8):1376-84
8702447
N Engl J Med. 2004 Nov 11;351(20):2069-79
15537905
Science. 2007 Jul 13;317(5835):256-60
17569825
Arthritis Rheum. 2004 Apr;50(4):1270-6
15077311
Arthritis Rheum. 1994 Jun;37(6):869-77
8003059
Immunity. 2007 Mar;26(3):371-81
17363300
Ann Rheum Dis. 2002 Jun;61(6):554-8
12006334
Immunol Rev. 2008 Dec;226:132-46
19161421
Ann Rheum Dis. 2006 Jan;65(1):112-4
16344495
J Exp Med. 2003 Dec 15;198(12):1875-86
14676299
Nature. 2008 May 8;453(7192):236-40
18368049
Arthritis Res Ther. 2005;7(6):R1281-8
16277681
Arthritis Rheum. 2007 Dec;56(12):3977-88
18050195
J Immunol. 1998 Apr 1;160(7):3513-21
9531313
Arthritis Rheum. 2004 Jul;50(7):2240-5
15248223